GLENMARK PHARMACEUTICALS LIMITED
ent_019fd5fc6a1b9060f8c8b9ae316d38ea
Disclosures
0
— · 0 jurisdictions
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- GLENMARK PHARMACEUTICALS LIMITED
- Normalized
- glenmark pharmaceuticals— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 335800WKECZXIIT9GK20
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- None on record
Disclosure history (0)newest first
No disclosures linked to this entity yet.
Subsidiary disclosures (2)filed by group companies
◈ These filings were made by or about subsidiaries of GLENMARK PHARMACEUTICALS LIMITED — not by GLENMARK PHARMACEUTICALS LIMITED itself. Corporate relationships are mapped from GLEIF relationship records and SEC Exhibit 21 filings.
- Massachusetts State AGvia GLENMARK PHARMACEUTICALS INC., USA2026-03-27
Glenmark Pharmaceuticals Inc., USA notified individuals of a security incident after receiving an extortion email on February 27, 2026, claiming possession of company records. The investigation identified documents containing government-issued identification numbers. The company engaged external cybersecurity professionals and law enforcement. Two years of identity protection services are being offered. The investigation is ongoing.
- Indiana State AGvia GLENMARK PHARMACEUTICALS INC., USA2026-03-17
Glenmark Pharmaceuticals Inc USA reported a data breach to the Indiana Attorney General. The breach occurred on 2026-02-27 and was reported on 2026-03-17. 1 Indiana residents were affected.